Skip to content

Preparation and Feasibility of Exams for Expected Studies

Preparation and Feasibility of Exams for Expected Studies (PRELUDE)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05698810
Acronym
PRELUDE
Enrollment
150
Registered
2023-01-26
Start date
2023-03-20
Completion date
2033-03-20
Last updated
2025-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers, Para/Tetraplegic Patients, Parkinson's Disease Patients

Brief summary

Feasibility study: the examinations carried out as part of this protocol aim to carry out all the acquisitions and simulations of use, necessary for the development of the clinical research protocols to come to Clinatec (in particular, configuration of the equipment, dimension of the examination time and the size of the cohorts etc ...)

Detailed description

To ensure the feasibility of a clinical trial, it is necessary to test the parameters as well as the sequence of the different examination times offered to participants. The expected results of this protocol are mainly the dimension of experimental paradigms and the optimization of the clinical management of subjects.

Interventions

OTHERCE marked Medical Device MagnetoEncephaloGraphy (MEG) usability

tests

OTHERCE marked Medical Device Magnetic Resonance Imaging (MRI) usability

tests

OTHERCE marked Medical Device ElectroEncephaloGraphy (EEG) usability

tests

OTHERCE marked Medical Device ElectroCardioGraphy (ECG) usability

tests

Sponsors

Commissariat A L'energie Atomique
CollaboratorOTHER_GOV
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

volunteers

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ⩾ 18 years * Affiliated to a social security scheme * Free and informed consent signed

Exclusion criteria

* Subject in a period of exclusion from another study. * Subject deprived of liberty by a judicial or administrative decision, or major subject subject to a legal protection measure (guardianship, curatorship and safeguarding of justice) referred to in Articles 1121-6 to 1121-8 of the Public Health Code. * Subject who would receive more than 4500 euros in compensation because of his participation in other research involving the human person in the 12 months preceding this study. * Pregnant woman, parturient, nursing mother (Article 1121-5 of the Public Health Code) * Subject not reachable urgently.

Design outcomes

Primary

MeasureTime frameDescription
ECG physiological parameters measurements that will be used in future clinical researchthrough study completion, an average of 10 yearsAdequacy of ECG physiological parameters measurements to the needs of the protocol and duration of the paradigm consistent with the cooperation of the subject
MEG physiological parameters measurements that will be used in future clinical research protocolsthrough study completion, an average of 10 yearsAdequacy of MEG physiological parameters measurements to the needs of the protocol and duration of the paradigm consistent with the cooperation of the subject
MRI physiological parameters measurements that will be used in future clinical researchthrough study completion, an average of 10 yearsAdequacy of MRI physiological parameters measurements to the needs of the protocol and duration of the paradigm consistent with the cooperation of the subject
EEG physiological parameters measurements that will be used in future clinical researchthrough study completion, an average of 10 yearsAdequacy of EEG physiological parameters measurements to the needs of the protocol and duration of the paradigm consistent with the cooperation of the subject

Secondary

MeasureTime frameDescription
MEG physiological parameters data collection paradigmsthrough study completion, an average of 10 yearsAchieving MEG physiological parameters data collection paradigms
MRI physiological parameters data collection paradigmsthrough study completion, an average of 10 yearsAchieving MRI physiological parameters data collection paradigms
EEG physiological parameters data collection paradigmsthrough study completion, an average of 10 yearsAchieving EEG physiological parameters data collection paradigms
ECG physiological parameters data collection paradigmsthrough study completion, an average of 10 yearsAchieving ECG physiological parameters data collection paradigms

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026